Is a 24-hour fast beneficial for a healthy adult with no significant medical history, and what are the potential risks for individuals with underlying medical conditions, such as diabetes, or those taking medications like metformin or insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

24-Hour Fasting: Evidence-Based Recommendations

For healthy adults without diabetes or cardiovascular disease, a 24-hour fast is generally safe and may provide modest metabolic benefits, but eating windows should never be restricted to less than 8 hours daily due to increased cardiovascular mortality risk. 1, 2

For Healthy Adults

Potential Benefits

  • Weight loss of 1-8% from baseline can occur when fasting is combined with caloric restriction, though this is modest and not significantly different from continuous calorie restriction 3, 4
  • Triglyceride reductions of 16-42% have been documented with time-restricted eating regimens 1, 4
  • Blood pressure improvements affect both systolic and diastolic measurements 1
  • Insulin sensitivity improves with accompanying decreases in fasting glucose, particularly beneficial for metabolically unhealthy individuals 1, 4

Critical Safety Parameters

  • The American College of Cardiology recommends an 8-12 hour eating window as the optimal balance between metabolic benefits and cardiovascular safety 1
  • Never restrict eating to less than 8 hours daily - analysis of 20,000 U.S. adults found this significantly increased cardiovascular disease mortality risk compared to 12-16 hour eating windows 1, 2

Absolute Contraindications (Do Not Fast)

Cardiac Conditions

The European Society of Cardiology identifies specific high-risk conditions where fasting must be avoided: 1, 2

  • Acute coronary syndrome
  • Advanced heart failure
  • Recent percutaneous coronary intervention or cardiac surgery
  • Severe aortic stenosis
  • Poorly controlled arrhythmias
  • Severe pulmonary hypertension

Diabetes-Related Contraindications

  • Type 1 diabetes patients should be strongly advised against fasting due to very high risk of severe hypoglycemia and diabetic ketoacidosis 1, 5
  • Pregnant women with any form of diabetes face high morbidity and mortality risk to both fetus and mother 1, 5
  • Patients with recurrent hypoglycemia or hypoglycemia unawareness should avoid fasting 1
  • Very elderly Type 2 diabetes patients requiring insulin for many years should avoid fasting 1

Cancer Patients

  • The European Society for Clinical Nutrition and Metabolism recommends against fasting during chemotherapy due to malnutrition risk, despite theoretical benefits 6, 2
  • Patients who are malnourished or at risk of malnutrition should not use dietary provisions that restrict energy intake 6

High-Risk Populations Requiring Intensive Medical Supervision

Type 2 Diabetes on Medications

Metformin alone (relatively safe): 1

  • Hypoglycemia risk is minimal
  • Adjust dosing to two-thirds of total daily dose immediately before the sunset meal
  • One-third before the predawn meal
  • Requires glucose monitoring but generally well-tolerated

Sulfonylureas (high risk): 1

  • Carry inherent hypoglycemia risk during fasting
  • Require individualized, cautious use with dose adjustments
  • For once-daily: shift entire dose to before sunset meal
  • For twice-daily: half the usual morning dose at predawn, full dose at sunset

Insulin users (very high risk): 1, 5

  • Face similar risks to Type 1 diabetes, though hypoglycemia incidence is lower
  • Require significant dose reduction (typically 20% for basal insulin on higher doses)
  • Multiple daily glucose checks are mandatory - before predawn meal, mid-day during fast, before sunset meal, and 2 hours post-sunset meal 5
  • Target fasting glucose between 90-150 mg/dL 5
  • Complete insulin cessation risks diabetic ketoacidosis 5

Glitazones (low risk): 1

  • Low hypoglycemia risk
  • Usually require no dose change during fasting

Warfarin/Anticoagulation Users

  • Fluid restriction and dehydration during fasting increase thrombotic event risk, particularly in older patients with hypertension and dyslipidemia 1, 2
  • Dietary changes affect warfarin stability
  • Ensure adequate hydration during non-fasting periods 1

Practical Implementation Algorithm

Step 1: Screen for Absolute Contraindications

  • Review cardiac history for conditions listed above 1, 2
  • Assess diabetes type and control 1, 5
  • Evaluate pregnancy status in women with diabetes 1, 5
  • Check for malnutrition or active cancer treatment 6, 2

Step 2: Risk Stratification for Diabetes

  • Type 1 diabetes or insulin-dependent Type 2 with poor control: Strong advice against fasting 1, 5
  • Type 2 diabetes on diet alone: Quite low risk, but distribute calories over 2-3 smaller meals during non-fasting interval 1
  • Type 2 diabetes on oral agents: Assess medication-specific risks as outlined above 1

Step 3: Establish Safe Fasting Parameters

  • Set 8-12 hour eating window, never shorter than 8 hours 1, 2
  • For 24-hour fasts, this means planning meals within this window before and after the fast
  • Ensure adequate hydration during non-fasting periods 1

Step 4: Monitoring Protocol

  • First 3-4 weeks require close follow-up with frequent glucose checks if diabetic 1
  • For insulin users: check glucose at least 4 times daily during fasting periods 5
  • Adjust insulin by 2 units if ≥50% of readings exceed 150 mg/dL over one week 5
  • Decrease insulin by 2 units if >2 readings per week fall below 80 mg/dL 5

Metabolic Effects in Non-Diabetic Individuals

Acute 24-Hour Fast

  • Plasma glucose normalizes in individuals with mild to moderate untreated diabetes, decreasing from approximately 158 mg/dL to 104 mg/dL within 11 hours 7
  • Glycogenolysis provides approximately 700 kcal energy from roughly 167g of glycogen during the first 24 hours 7
  • Insulin concentrations decrease to within normal limits 7

Longer-Term Intermittent Fasting

  • Energy intake decreases by 10-30% from baseline with various fasting regimens 4
  • Oxidative stress and insulin resistance decrease 4
  • Appetite regulation may improve, though evidence is limited 4

Common Pitfalls to Avoid

Medication Management Errors

  • Never completely stop insulin in Type 1 diabetes - this risks diabetic ketoacidosis 5
  • Do not assume metformin is risk-free - dose timing adjustments are still necessary 1
  • Sulfonylureas require proactive dose reduction, not reactive management after hypoglycemia occurs 1

Overly Restrictive Eating Windows

  • Avoid the temptation to restrict eating to less than 8 hours despite popular diet trends - this increases cardiovascular mortality 1, 2
  • Patients may be tempted to prolong fasting episodes without medical supervision 6

Inadequate Hydration

  • Dehydration is a major risk, particularly for patients on anticoagulation 1, 2
  • Emphasize fluid intake during non-fasting periods

Lack of Pre-Fasting Education

  • Patients must receive education on signs and symptoms of hypoglycemia and hyperglycemia before any fasting period 5
  • Ensure availability of glucose tablets or glucose-containing liquids for immediate hypoglycemia treatment 5
  • Patients should know when to break the fast 5

Special Considerations

Pre-Operative Fasting

  • Prolonged fasting for elective surgery serves no purpose and adversely affects patient well-being 6
  • Modern guidelines support much shorter fasting times than traditionally practiced 6
  • This is distinct from voluntary 24-hour fasting for metabolic benefits 6

Religious Fasting (Ramadan)

  • The evidence base for 24-hour fasting largely derives from Ramadan fasting studies 6, 8
  • Patients with ascites, hepatic coma, hematemesis, or high risk for low blood sugar should be advised against fasting regardless of underlying liver disease severity 6
  • Gilbert's syndrome patients can fast with regular bilirubin monitoring 6

References

Guideline

Intermittent Fasting: Cardiovascular and Metabolic Benefits and Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Extended Fasting: Metabolic Benefits and Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Health effects of intermittent fasting: hormesis or harm? A systematic review.

The American journal of clinical nutrition, 2015

Research

Cardiometabolic Benefits of Intermittent Fasting.

Annual review of nutrition, 2021

Guideline

Insulin Administration During Fasting in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Is three to five day fasting (intermittent fasting) scientifically supported for health improvement?
What are the current guidelines for safe fasting, especially for individuals with underlying health conditions?
What are the health benefits of fasting for more than 48 hours (forty-eight hours), specifically prolonged fasting?
What are the health benefits and risks of extended fasting, particularly for individuals with pre-existing medical conditions like diabetes or those taking medications such as warfarin (coumarin) or insulin?
What are the benefits and risks of the 20:4 (20 hours fasting, 4 hours eating) intermittent fasting method?
What is the best course of action for an elderly male patient with stage 3b chronic kidney disease (CKD) and a history of pedal edema, who is currently taking multiple medications including hydrochlorothiazide (HCTZ), and has shown improvement in pedal edema after discontinuing a previous medication?
Is statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor) contraindicated in patients with myasthenia gravis?
What are the considerations for using Total Intravenous Anesthesia (TIVA) with halogenated gases in patients with significant cardiovascular or respiratory disease undergoing major surgery?
What is the recommended dosage and treatment duration of Dutasteride (dutasteride) for an adult male with benign prostatic hyperplasia (BPH) or androgenetic alopecia?
What is the effect of statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) on Lipoprotein(a) (Lp(a)) levels in patients with elevated Lp(a) and high cardiovascular risk?
What alternative diuretic can be given to a patient with a urinary tract infection (UTI) and pneumonia who is allergic to furosemide (Lasix)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.